Publication | Closed Access

Discovery of chalcone-modified estradiol analogs as antitumour agents that Inhibit tumour angiogenesis and epithelial to mesenchymal transition

Tumor BiologyChalcone-modified Estradiol AnalogsMedicineTumor TargetingAnti-cancer AgentInhibit Tumour AngiogenesisCancer TreatmentPharmacologyCell BiologyTumor MicroenvironmentCancer ResearchCancer GrowthAntitumour Agents